跳至主要内容
临床试验/JPRN-UMIN000004354
JPRN-UMIN000004354已完成未知

Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial. - LIST study

Department of Urology, Kanto Rosai Hospital0 个研究点目标入组 60 人开始时间: 2010年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Contraindication to anti-cholinergic agents. (Primary angle-closure glaucoma , urinary retention , Obstructive intestinal disease, paralytic ileus, gastrointestinal atony, myastania gravis) 2)Residual urine >=100mL. 3)Suspect of prostate cancer. 4)Active urinary tract infection. 5)Judged as being unsuitable for the trial by the researcher.

研究者

发起方
Department of Urology, Kanto Rosai Hospital

相似试验